SARS-CoV-2 expresses a microRNA-like small RNA able to selectively repress host genes

This article has been Reviewed by the following groups

Read the full article See related articles

Abstract

We discovered that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) expresses a small viral noncoding RNA, named CoV2-miR-O7a (for SARS-CoV-2 miRNA-like ORF7a-derived small RNA). CoV2-miR-O7a associates with the cellular RNA interference machinery and has the potential to regulate host transcripts, likely via target slicing. The production of CoV2-miR-O7a relies on cellular machinery and the formation of a strong hairpin within ORF7a sequences. This newly described CoV2-miR-O7a may contribute to SARS-CoV-2 pathogenesis and could become a target for therapeutic intervention.

Article activity feed

  1. SciScore for 10.1101/2021.09.08.459464: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    Ethicsnot detected.
    Sex as a biological variablenot detected.
    Randomizationnot detected.
    Blindingnot detected.
    Power Analysisnot detected.
    Cell Line Authenticationnot detected.

    Table 2: Resources

    Antibodies
    SentencesResources
    After 30 min of cell lysis inside the BSC, the nuclei were pelleted and supernatants were transferred to 2.0 ml screw-top tubes with O-rings containing magnetic beads (SureBeads Protein G Magnetic Beads, NEB) coupled to antibodies (anti-pan Ago antibody, clone 2A8; Sigma Millipore). 10% of supernatants were kept for input (in TRIzol).
    anti-pan Ago antibody ,
    suggested: (Millipore Cat# MABE56, RRID:AB_10807962)
    Primary antibodies used were anti-FLAG M2 (Sigma Millipore)
    anti-FLAG
    suggested: None
    Experimental Models: Cell Lines
    SentencesResources
    PC-9 cells (kind gift from Dr. Craig Wilen) were cultured in RPMI medium (GIBCO) with 10% FBS and Pen/Strep. A549 (ATCC) cells were transduced as described previously (27) with hACE2 plasmid and cultured in F-12 medium (GIBCO) with 10% FBS, Pen/Strep and 1 μg/ml of puromycin (GIBCO).
    PC-9
    suggested: None
    A549
    suggested: None
    Vero-E6 (ATCC), Huh7.5 and Huh7.5 Drosha knockout (kind gift from Dr. Charles Rice; (32)) cells were cultured in DMEM with 10% FBS, and Pen/Strep.
    Huh7.5
    suggested: RRID:CVCL_7927)
    Calu-3 cells were transduced either with FLAG-HA-Ago2 (27) or pLVX (for empty vector control) and cultured in the presence of 1 μg/ml of puromycin.
    Calu-3
    suggested: BCRJ Cat# 0264, RRID:CVCL_0609)
    Virus titers were determined by plaque assay using Vero-E6 cells.
    Vero-E6
    suggested: None
    Immunoprecipitation: For anti-pan Ago IP, 5×105 of Calu-3 cells or 1×105 of A549-hACE2 cells were infected with SARS-CoV-2 at MOI 5 for 24h.
    A549-hACE2
    suggested: RRID:CVCL_A5KB)
    Synthetic RNA transfections and qPCR: Synthetic RNAs (see Table 2 for sequences) were annealed by heating equimolar concentrations for 1 min at 90°C in siRNA buffer (Horizon, 60 mM KCl, 6 mM HEPES-pH 7.5, 0.2 mM MgCl2) and then incubating for 1 h at 37°C. 5×105 HEK293T cells were transfected with 30 μM of either vmiR-5p or control siRNA, by using Lipofectamine RNAiMAX Transfection Reagent (Invitrogen).
    HEK293T
    suggested: None
    Recombinant DNA
    SentencesResources
    PC-9 cells (kind gift from Dr. Craig Wilen) were cultured in RPMI medium (GIBCO) with 10% FBS and Pen/Strep. A549 (ATCC) cells were transduced as described previously (27) with hACE2 plasmid and cultured in F-12 medium (GIBCO) with 10% FBS, Pen/Strep and 1 μg/ml of puromycin (GIBCO).
    hACE2
    suggested: RRID:Addgene_1786)
    Calu-3 cells were transduced either with FLAG-HA-Ago2 (27) or pLVX (for empty vector control) and cultured in the presence of 1 μg/ml of puromycin.
    pLVX
    suggested: RRID:Addgene_101121)
    The PCR products were cloned downstream of Renilla luciferase of psiCHECK(TM)-2 vector (Promega) using XhoI and NotI sites.
    psiCHECK(TM)-2
    suggested: None
    Cells were collected 6 h later, RNA extractions were performed using TRIzol and samples were processed for Northern blotting as described above. 2 4h later, 10 ng psiCHECK reporters and 2 μg pBlueScript II (Stratagene) were transfected using TransIT-293 Transfection Reagent (Mirus).
    pBlueScript
    suggested: None
    Software and Algorithms
    SentencesResources
    After 3 days the supernatant was harvested and clarified by centrifugation, concentrated on Ultra-15 Centrifugal Filters (Amicon), aliquoted and stored at −80°C.
    Amicon
    suggested: None
    The reads were mapped with bowtie2 (65) (--very-sensitive-local) to an index containing human and SARS-CoV-2 genomes.
    bowtie2
    suggested: (Bowtie 2, RRID:SCR_016368)
    miRNAs were counted by using featureCounts (66) and annotations obtained from miRbase (67).
    featureCounts
    suggested: (featureCounts, RRID:SCR_012919)
    miRbase
    suggested: (miRBase, RRID:SCR_003152)
    Differential expression was determined using edgeR (68).
    edgeR
    suggested: (edgeR, RRID:SCR_012802)
    Track visualization was performed using an IGV browser (69) of generated with BEDtools (70) bed files.
    BEDtools
    suggested: (BEDTools, RRID:SCR_006646)
    Patient samples and quantitative RT-PCR: The human study reported here from which nasopharyngeal swab samples were obtained was approved by the Yale Human Research Protection Program, (Protocol 2000027971).
    Yale Human Research Protection Program
    suggested: None
    Densitometry was performed by using Quantity One. miR-210-3p target and re-analysis of public data: Counts from RNA-seq experiments of lung biopsies were obtained from (14, 15).
    Quantity One.
    suggested: None
    Primary antibodies used were anti-FLAG M2 (Sigma Millipore)
    Sigma Millipore
    suggested: (Penn Cell Center Stockroom, RRID:SCR_010003)
    Target predictions: Custom Perl scripts that use the RNAduplex algorithm — part of the Vienna RNA Package (53) — were used to hybridize the vmiR-5p sequence to mRNA transcripts obtained from GENCODE (v38) (74) fragmented into 50-nt windows with 5-bp steps.
    GENCODE
    suggested: (GENCODE, RRID:SCR_014966)

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).


    Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.

    Results from TrialIdentifier: No clinical trial numbers were referenced.


    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.


    Results from JetFighter: We did not find any issues relating to colormaps.


    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    Results from scite Reference Check: We found no unreliable references.


    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.